Department of Pharmacy Practice

Eric G. Sahloff, Pharm.D.

Photo of Dr. Sahloff

Associate Professor of Clinical Pharmacy
Department of Pharmacy Practice

Frederic and Mary Wolfe Center 114B 


  • Critical Care/Infectious Diseases Pharmacotherapy Fellowship, University of Toledo
  • Critical Care/Infectious Diseases Specialty Residency, St. Vincent Mercy Medical Center
  • Doctor of Pharmacy, the University of Toledo
  • Bachelor of Science, Pharmacy, the University of Toledo
  • Bachelor of Arts, Biology, The University of Toledo

Scope of Practice and Curriculum

Infectious Disease - HIV

Professional Experience

  • Associate Professor of Pharmacy Practice, The University of Toledo
  • Adjunct Assistant Professor, Department of Medicine
  • Co-Director, College of Pharmacy Continuing Education Program
  • Clinical Pharmacist, the University of Toledo Medical Center

Recent Publications


  1. Fink B, Duggan JM, Sahloff EG. Nutritional status of HIV infected consumers in an economically depressed region of the United States. Presented at the XIX International AIDS Conference – AIDS 2012, Washington D.C., July 2012.
  2. Mospan G, Jung R, Georgescu C, Sahloff E, Duggan J. Evaluation of ceftriaxone for bacteremia due to methicillin-susceptible Staphylococcus aureus. Presented at ASHP Midyear, December 2012; OCCP, May 2013.
  3. Lewis S, Sahloff E, Jung R. Gender differences in virologic outcomes in HIV-infected patients on HAART. Presented at ASHP Midyear, December 2012; OCCP, May 2013.

Peer-Reviewed Articles

  1. Jacobs DM, Duggan JM, Sahloff EG. Gingival Hypertrophy Associated with Amlodipine Use in Infected Woman. J Pharm Technol 2013;29:175-7.
  2. Peeters MJ, Sahloff EG, Stone G. Reliability and validity in performance-based evaluation: a 2-year experience in PharmD oral presentations using multiple faculty evaluators and a standardized rubric. Am J Pharm Ed 2010;74:Article 171.
  3. Pinto S, Sahloff EG, Ramasamy A. Evaluating the validity and reliability of a modified survey to assess patient satisfaction with mail-order and community pharmacy settings. J Pharm Pract 2009. Published online:
  4. Yost R, Pasquale TR, Sahloff EG. Maraviroc: the first approved CCR5-antagonist for the management of HIV-infection. Am J Health Syst Pharm 2009;66: 715-726.
Last Updated: 6/30/19